Cargando…
Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection
COVID-19 infection displays heterogeneity of clinical manifestations in symptomatic and asymptomatic patients. We report on a child with Miller Fischer syndrome (MFS) and posterior reversible encephalopathy syndrome (PRES) post-COVID-19 infection. An 11-year-old boy presented with vomiting, headache...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Riyadh : Armed Forces Hospital
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926123/ https://www.ncbi.nlm.nih.gov/pubmed/34230086 http://dx.doi.org/10.17712/nsj.2021.3.20210002 |
_version_ | 1784670170609876992 |
---|---|
author | Al Haboob, Ali A. |
author_facet | Al Haboob, Ali A. |
author_sort | Al Haboob, Ali A. |
collection | PubMed |
description | COVID-19 infection displays heterogeneity of clinical manifestations in symptomatic and asymptomatic patients. We report on a child with Miller Fischer syndrome (MFS) and posterior reversible encephalopathy syndrome (PRES) post-COVID-19 infection. An 11-year-old boy presented with vomiting, headache, blurred vision, dysarthria, dysphagia, respiratory failure, muscle weakness, and unsteadiness. He had been exposed to COVID-19 through an asymptomatic elder brother two months prior to his illness. The MRI brain showed findings consistent with PRES and the diagnosis with Miller Fischer variant of the Guillain-Barré syndrome was made. A cerebrospinal fluid analysis revealed cytoalbuminous dissociation, and a nerve conduction velocity study conclusively showed polyneuropathy. A fluoroscopy of the diaphragms found that there was limited movement in both. Although children seem to be less affected by COVID-19 infection, this report highlights on an important neurological complications that can develop in children and its presence should be taken into consideration when diagnosing different forms of Guillain-Barré. |
format | Online Article Text |
id | pubmed-8926123 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Riyadh : Armed Forces Hospital |
record_format | MEDLINE/PubMed |
spelling | pubmed-89261232022-03-24 Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection Al Haboob, Ali A. Neurosciences (Riyadh) Case Reports COVID-19 infection displays heterogeneity of clinical manifestations in symptomatic and asymptomatic patients. We report on a child with Miller Fischer syndrome (MFS) and posterior reversible encephalopathy syndrome (PRES) post-COVID-19 infection. An 11-year-old boy presented with vomiting, headache, blurred vision, dysarthria, dysphagia, respiratory failure, muscle weakness, and unsteadiness. He had been exposed to COVID-19 through an asymptomatic elder brother two months prior to his illness. The MRI brain showed findings consistent with PRES and the diagnosis with Miller Fischer variant of the Guillain-Barré syndrome was made. A cerebrospinal fluid analysis revealed cytoalbuminous dissociation, and a nerve conduction velocity study conclusively showed polyneuropathy. A fluoroscopy of the diaphragms found that there was limited movement in both. Although children seem to be less affected by COVID-19 infection, this report highlights on an important neurological complications that can develop in children and its presence should be taken into consideration when diagnosing different forms of Guillain-Barré. Riyadh : Armed Forces Hospital 2021-07 /pmc/articles/PMC8926123/ /pubmed/34230086 http://dx.doi.org/10.17712/nsj.2021.3.20210002 Text en Copyright: © Neurosciences https://creativecommons.org/licenses/by-nc/3.0/Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. |
spellingShingle | Case Reports Al Haboob, Ali A. Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection |
title | Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection |
title_full | Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection |
title_fullStr | Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection |
title_full_unstemmed | Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection |
title_short | Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection |
title_sort | miller fischer and posterior reversible encephalopathy syndromes post covid-19 infection |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926123/ https://www.ncbi.nlm.nih.gov/pubmed/34230086 http://dx.doi.org/10.17712/nsj.2021.3.20210002 |
work_keys_str_mv | AT alhaboobalia millerfischerandposteriorreversibleencephalopathysyndromespostcovid19infection |